(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one

C20H30N4O2 — CID 164696666

IUPAC(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
SMILESCCC[C@H]1[C@H]2C[C@H](CN(Cc3cc(=O)[nH]c(C)n3)C2)[C@@H]2CCCC(=O)N21
InChIInChI=1S/C20H30N4O2/c1-3-5-17-14-8-15(18-6-4-7-20(26)24(17)18)11-23(10-14)12-16-9-19(25)22-13(2)21-16/h9,14-15,17-18H,3-8,10-12H2,1-2H3,(H,21,22,25)/t14-,15+,17-,18-/m0/s1
InChIKeyBOKIVVHQQXOUKX-MVJTYMMSSA-N
MW358.49 g/mol
LogP2.08
Rot. Bonds4

About (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one

(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one (PubChem CID 164696666) has the molecular formula C20H30N4O2 and a molecular weight of 358.49 g/mol. Its IUPAC name is (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one.

Molecular Properties

Compound Name(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
PubChem CID164696666
Molecular FormulaC20H30N4O2
Molecular Weight358.49 g/mol
Exact Mass358.24
IUPAC Name(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
SMILESCCC[C@H]1[C@H]2C[C@H](CN(Cc3cc(=O)[nH]c(C)n3)C2)[C@@H]2CCCC(=O)N21
InChIInChI=1S/C20H30N4O2/c1-3-5-17-14-8-15(18-6-4-7-20(26)24(17)18)11-23(10-14)12-16-9-19(25)22-13(2)21-16/h9,14-15,17-18H,3-8,10-12H2,1-2H3,(H,21,22,25)/t14-,15+,17-,18-/m0/s1
InChIKeyBOKIVVHQQXOUKX-MVJTYMMSSA-N
XLogP2.08
TPSA69.30 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500358.49
LogP ≤ 52.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The IUPAC name of (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one (CID 164696666) is (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one.
What is the SMILES notation for (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The canonical SMILES for (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one is CCC[C@H]1[C@H]2C[C@H](CN(Cc3cc(=O)[nH]c(C)n3)C2)[C@@H]2CCCC(=O)N21.
What is the InChIKey of (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The InChIKey is BOKIVVHQQXOUKX-MVJTYMMSSA-N. The full InChI is InChI=1S/C20H30N4O2/c1-3-5-17-14-8-15(18-6-4-7-20(26)24(17)18)11-23(10-14)12-16-9-19(25)22-13(2)21-16/h9,14-15,17-18H,3-8,10-12H2,1-2H3,(H,21,22,25)/t14-,15+,17-,18-/m0/s1.
What are the key properties of (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
(1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one has a molecular weight of 358.49 g/mol, XLogP of 2.08, 4 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,8S,9S)-11-[(2-methyl-6-oxo-1H-pyrimidin-4-yl)methyl]-8-propyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one is sourced from PubChem (CID 164696666), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).